Vous êtes sur la page 1sur 11

Jubilant bhartia group

The Jubilant Bhartia Group embarked on a

journey to create leadership in its chosen
areas of business over two decades ago. The
Group has a strong presence in Pharma, life
sciences and healthcare sector through its
flagship company Jubilant Organosys and
has the fastest growing Dominos pizza chain
in India through Jubilant FoodWorks. The
group is a leading Indian private sector
player in oil and gas exploration and
production business through Jubilant
Energy. Through a clutch of independent
Companies the group has a significant
presence in Retail segment including
Hypermarkets and Automobiles. The Group
also offers a wide range of marketing and
technical services for international
companies in the area of aviation, oil & gas
services and power and infrastructure
Jubilant identified the increased globalization of Indian economy and its first alignment with
international economic trends, adapted these changes and spread its wings to the outer world and
moved away from being industry oriented to sharing knowledge. Headquartered in India the
group has built strong business in North America with significant investments over the last
decade. Through it various entities the group is engaged in business in over 60 countries across
the world.

The four core segments of Jubilant Bhartia Group are:

Pharmaceutical, Life sciences and Healthcare
Jubilant Organosys Limited is an integrated pharmaceuticals and Life Sciences Company. . It
is the largest Custom Research and Manufacturing Services player and one of the leading drug
discovery and development solution provider from India It is well positioned as an outsourcing
partner for the global pharma and life sciences companies. read more »

Oil and Gas Exploration and Production

Jubilant Energy is one of the leading companies in private sector engaged in Oil & Gas
exploration and production (E&P) in India and overseas. It has collaborations with leading
global companies and currently operates 12 blocks - 8 in India, 3 in Yemen and 1 in Australia.
read more »

Food & Retail

Jubilant FoodWorks Limited holds the Master Franchisee Rights for the Domino's Pizza, for
India, Nepal, Sri Lanka and Bangladesh. The company has been listed on the Indian Bourses
recently and is the fastest growing dominos pizza country in the world with 300 stores in India.

The brand, Domino's Pizza, was founded in the US in 1960 by Thomas and James Monaghan.
Since then, it has grown into a global network of 9000 pizza stores in more than 60 countries
around the world. read more »

Jubilant is present in two formats in retail: hypermarkets (Total) and supermarkets.

Jubilant Retail is a Bangalore-based retail chain running state-of-the-art hypermarkets and

malls. Its hypermarket branded as 'Total' is designed on the lines of international shopping malls
and is a single-point food store carrying packaged, processed as well as fresh food and beverage
items. It also stocks non-food items like apparel, sports goods, bed and linen, furniture, etc.

Jubilant Motorworks, the Group through Jubilant Motors is engaged in sales and servicing of
Audi Cars through state of art showrooms in Bangalore and Chennai. Audi has been well
recognised globally as a manufacturer of high-quality and innovative luxury cars, it is one of the
world's leading premium brands which is among the most admired car brands across the world.
Audi has a presence in over 110 countries and it set up shop in India in 2004.

Jubilant Enpro, through its alliances with international companies, provides business,
marketing and technical support related to Oil & Gas services, Power & Infrastructure services,
and Aviation related services (sales/maintenance of aircrafts & helicopters). read more»

A shared vision and a common set of values bind all diverse businesses of the Jubilant Group.
So far, Jubilant has created a strong global presence in the pharmaceutical and life sciences
sectorand in the other areas the group is moving ahead steadfastly gaining remarkable
experience and growth. Over the years Jubilant has successfully established itself as a partner
of choice in an ever-changing environment that presents both opportunities and challenges for
its various businesses. The focus on servicing customers and building partnerships to create
value has generated significant stakeholder return and aptly reflects the group's promise of
Caring, Sharing and Growing.
Corporate overview

Jubilant Organosys Limited, an integrated pharmaceutical industry player, is the largest Custom
Research and Manufacturing Services (CRAMS) Company and one of the leading Drug
Discovery and Development Solutions (DDDS) Companies from India. It is successfully
positioned as "an outsourcing partner of choice" to global life sciences companies. Leveraging its
focus on innovation and customer satisfaction the Company serves its customers in over 65
countries around the world.

The Company headquartered in India, has a presence across the pharmaceuticals value chain and
offers products and services ranging from Life Sciences chemicals, Advance Intermediates &
Fine Chemicals, Active Pharmaceutical Ingredients, Sterile Injectables, Generic Dosage Forms,
Specialty Pharmaceuticals, to Drug Discovery, Medicinal Chemistry, Clinical Research services
and Healthcare.

Pharma and Life Sciences Products & Services (PLSPS)

It is a major building block of the Company constituting 89% of the overall business. This
business constitutes 2 key segments, Life Science Products(73%) and Pharmaceutical
Services(27%). Life Science Products segment is the growth driver of the business with over
70% share of the PLSPS revenue and over the years company's PLSPS business has gained
momentum and has successfully developed global delivery capabilities in key products.

Jubilant delivers products and services to the global life sciences industry by leveraging its R&D
expertise, knowledge driven operations and global scale manufacturing capacities.

As Partner of choice, Jubilant brings in added value such as Innovation, Continuous

Improvement, Financial Strength, Quality of Operations and Long Term Sustainability.

The Company offers products & services across the pharmaceutical value chain such as Advance
Intermediates, Custom Synthesis (Kilo to ton quantities), Proprietary Products (150 products for
more than 229 API and 17 Agro chemicals), Active Pharmaceutical Ingredients, Generic Dosage
Forms, Contract Manufacturing of Sterile Injectables (liquids and lyophilized), Non-Sterile
Products (ointments, creams and liquid), Radiopharmaceuticals, Allergenic Products and
manufacturing of Healthcare.
The Company provides Drug Discovery & Development Solutions comprising research services
ranging from various aspects of discovery including Biology, Medicinal Chemistry, Structural
Biology, Pharmacology, Molecular Modelling, ADME, Toxicology; Drug Development Services
including preclinical to phase I-IV, BA/BE/PK studies, Clinical Data Management to

Global Footprint

Jubilant employs ~ 6000 people across the globe including 1500

people outside India. The Company has offices in USA, Canada,
Europe, China and Japan besides India with international
subsidiaries in USA, Canada and Belgium.

Jubilant Organosys key subsidiary companies in India include

Jubilant Biosys Ltd, for discovery informatics and drug discovery
services; Jubilant Chemsys Ltd for medicinal chemistry; Clinsys
Clinical Research Ltd for clinical research and bio availability /
bio equivalence studies; Jubilant First Trust Healthcare Ltd for
high quality healthcare services.

The Companies key international subsidiaries are Draxis Specialty Pharmaceuticals Inc.,
Canada offering sterile products, non-sterile products & radiopharmaceuticals and is a US FDA
approved manufacturing facility. HollisterStier Laboratories, LLC, USA is a leading contract
manufacturer of Sterile Injectables vials, Lyophilization products & Allergenic Extracts and is a
US FDA approved manufacturing facility

Cadista Pharmaceuticals, Inc., USA is a dosage forms manufacturing facility and approved by
US FDA. Clinsys Clinical Research, Inc., USA is a full service clinical research organization
providing clinical research, clinical data management, biostatistics, QA / regulatory and contract
staffing services.

Jubilant Pharmaceuticals NV, Belgium provides regulatory affairs services and undertakes
development and supply of formulations to European customers.

Global Manufacturing
Jubilant Organosys has 11 geographically diversified manufacturing facilities in India, USA &
Canada. These facilities are GMP and GLP compliant and have ISO 9001:2000, ISO 14001 &
ISO 18001 accreditation. The plants are also approved by the relevant international regulatory

Over the last few years Jubilant has successfully integrated R&D, technology and engineering
capabilities and with implementation of Lean Six Sigma for continuous improvement and cost
management, the Company offers its customers the best in class products and services.
Key Global Positions

Life Science Ingredients Generics

• Globally No.1 in carbamazepine, • Leader in I-131 in USA with
Oxcarba-mazepine, Lamotrigines in ~69% market share
APIs and No.2 in Citalopram, • Globally among top 3 in several
Risperidone in generics Generics

• Globally No.1 in Pyridines & 11 • Globally among top 3 leading

Advanced Intermediates allergy therapy companies

Drug Discovery & Development

CMO – Sterile & Non Sterile Products
• Leading player in India in Drug
• Leading player in North America in
Discovery & Development
CMO for Sterile injectables

Agri Products & Performance Polymers

• Top 3 in India for Single Super Phosphates
• India No.1 and Globally No. 3 for food polymers
• V P Latex : India No.1 and Globally No. 4

• Consumer adhesives & polish brands of "Jivanjor" is the 2nd largest in India

Vision , promise and value

Jubilant symbolizes positivity, dynamism, triumph and joy, all of which guide and
shape the Group’s collective experiences and efforts. Jubilant will always care for
human needs, share its expertise to provide a better life and help upgrade the
stakeholders’ standard of living and sustainable growth by dynamizing the value
chain within the Group.

Our vision is to be amongst the top 10 most admired companies to work for. We
want to maintain our leadership position in our chosen area of business in India and
to establish it globally. We will endeavour to create new opportunities for growth in
our strategic businesses which give a 10 points higher rate of return than the cost
of capital.

Our values determine our business path. Combined with our Promise and Vision,
these values have determined what we have achieved and they continue to guide
our future.



We will carefully select, train and We stretch ourselves to be cost

develop our people to be creative, effective and efficient in all aspects
empower them to take decisions, so of our operations and focus on
that they respond to all customers flawless delivery to create and
with agility, confidence and provide the best value to our
teamwork customers
By sharing our knowledge and With utmost care for the
learning from each other and from environment and safety, we will
the markets we serve, we will always strive to excel in the quality
continue to surprise our customers of our processes, our products and
with innovative solutions our services

Manufacturing facilities
Jubilant's manufacturing capabilities are one of its key differentiators. The Company has
vertically integrated manufacturing facilities for its range of Custom Research and
Manufacturing Services, APIs, Dosage Forms, Industrial and Performance Products.

Jubilant Organosys has geographically diversified manufacturing facilities situated across India
at Gajraula (UP), Nanjangud (Karnataka), Roorkee (Uttarakhand), Nira (Maharashtra), Udaipur
(Rajasthan), Samlaya (Gujarat), Ambarnath (Mumbai) and internationally at Salisbury, state of
Maryland (USA), Spokane, state of Washington (USA) and Kirkland, state of Quebec (Canada).
The Company's manufacturing facility in Maryland & Spokane, USA, is US FDA, MHRA,
ANVISA & PMDA approved. The facility at Kirkland, Canada is US FDA approved. The Indian
cGMP compliant facility for manufacturing finished dosage forms in Roorkee, Uttarakhand is
operational and is UKMHRA approved.

Awards and recognition

Jubilant's rapid progress across all corporate aspects has consistently been acknowledged by
various industry bodies, government and non-government agencies in the form of awards and

ET – IMEA 2009 Platinum Award by Frost & Sullivan, in the
Pharmaceutical category for the API facility at Nanjangud

Best CFO (FMCG, Health and Retail Sector) to Mr. R.

Sankaraiah by Institute of Chartered Accountants of India in
January, 2010

NDTV Profit Business Leader of the Year 2009 as the Best
Pharmaceutical Company

PHD Chamber Annual Excellence Award 2009 - for Good

Corporate Citizen

Acharya PC Ray Award for Development of Indigenous

Technology- for 4DMAP

Industry Excellence Award 2009 from Institute of Engineers

India, Kolkata

Frost and Sullivan – India Excellence in Healthcare Award as

the Best Contract Research Manufacturing Organization of the

Bio-Services Company of the Year Award for Jubilant Biosys

by BioSpectrum Magazine

BioSpectrum- Person of the Year Award conferred upon Mr

Hari S Bhartia, Co-Chairman & Managing Director, Jubilant

Best performing CFO of the year for the pharma sector to Mr

R Sankaraiah by CNBC-TV18

Corporate Excellence Award as the Best Pharma Company

from the Amity University

Golden Peacock Global award for CSR Reporting
Golden Peacock Global award for CSR

Featured in the Top 10 company of India in Standard and

Poor’s in Environment, Social and Governance (ESG) index

Corporate Governance for the year 2006-07.This award is in
recognition of Jubilant having imbibed best corporate
governance practices

I "A+" rating by Global Reporting Initiative (GRI), an

International Agency developing Sustainability Reporting
Guidelines for Corporate Sustainability Report

This is the highest rating as awarded by GRI. With this,

Jubilant has become the 'First Company in the Global
Pharmaceutical Sector' to be rated "A+" by Global Reporting

Featured in the IFC document as one of the four company who

have successfully integrated sustainability in business

Invited to International meet in Moscow for presenting the

only case study from India on Public Private Partnership (PPP)
model (DOTs centre for TB treatment at Gajraula.)

Jubilant Sustainability Report 2007 short listed for Reader’s

Choice award from 800 reports Globally.

Certificate of Commendation from CII for its Sustainability


Finalist at the Bombay Stock Exchange award for CSR

Finalist at the National Golden Peacock award for CSR

Selected as one of the top 25 companies for Institute of
Company Secretaries of India National Award for Excellence
in Corporate Governance

Finalist in Golden Peacock Award for Excellence in Corporate


Golden Peacock Award for Corporate Social Responsibility

Golden Peacock Award for innovation management from
Institute of Directors

Best implemented 6 Sigma initiatives by CII

Acharya P C Ray Award for Development of Indigenous


Figured in Forbes Top 100 list of companies under $1 billion

in the Asia Pacific & European regions

Received National Energy Conservation Award from

Government of India in five out of last six years

Golden Peacock award for Innovation Management

The Greentech Foundation Award for Environment Excellence

The Energy Conservation Award (Chemical sector) from the

Government of India for the Gajraula unit

Best Managed Manufacturing Plant for Single super phosphate

by FAI

Top 5 Best Managed Workforce in India - Hewitt Award

The DSIR Award for Innovation in Chemicals & Allied


Recognition and Awards at Gajraula

Safety Awards at Nira
Awards at Nanjangud Plant